PORTLAND, Ore. (KOIN) – The former CEO of a Vancouver-based company who promised a drug that could treat HIV and potentially COVID-19 was indicted Tuesday on federal charges of defrauding investors.
Vancouver-based biotechnology company CytoDyn has reached a $12 million settlement with its former research contractor Amarex Clinical Research. CytoDyn has spent years developing leronlimab, an ...
VANCOUVER, Washington, Dec. 01, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized ...
Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative breast cancer VANCOUVER, Washington, Sept. 25, 2025 (GLOBE ...
VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results